Stockreport

How Recent Developments Are Shaping the Story for ARS Pharmaceuticals According to Analysts [Yahoo! Finance]

ARS Pharmaceuticals, Inc.  (SPRY) 
PDF ARS Pharmaceuticals has seen its fair value estimate lowered from $30.00 to $28.67 per share, reflecting new analyst research and slightly more cautious market sentiment [Read more]